News | February 08, 2022
Suven Pharma Q3FY22 PAT at Rs. 160.06 crore
Suven Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.
Suven Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.
The partnership includes multiple collaboration areas and is an important milestone for bringing cost-competitive biobased products to the market, with applications in the pharmaceutical, agricultural, cosmetics and personal care, and automotive industries
Biosynthetic Technologies produces estolides, a new class of biobased synthetic oils used in a number of applications, including motor oil, industrial lubricants, pharmaceuticals, and personal care.
Wockhardt has entered into an agreement with Russian Direct Investment Fund and Enso Healthcare to manufacture and supply Sputnik V and Sputnik Light vaccines against Covid-19
Key takeaways of recent quarter & conference call highlights
This is the ninth Covid-19 vaccine approved in India
The campaign aims to bring back focus on leprosy case detection, treatment and rehabilitation; especially in the context of neglect brought in by Covid-19 pandemic
Mangalam Drugs and Organics Limited has reported standalone financial results for the period ended December 31, 2021
Dishman Carbogen Amcis has reported consolidated financial results for the period ended December 31, 2021
Sanofi unveiled a new bold and unifying corporate brand that supports the modernization and transformation the company launched in December 2019
Subscribe To Our Newsletter & Stay Updated
